for females ages 18-100 (full criteria)
at Orange, California and other locations
study started
estimated completion
Karen Noblett



The purpose of this study is to compare transvaginal mesh repair to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.

Official Title

A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of Uphold LITE Versus Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse


The primary objective is to evaluate clinical effectiveness of transvaginal repair with mesh (Uphold LITE) against traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse. Secondary objectives are to evaluate Uphold LITE-related complications and subject reported outcomes.

The primary endpoint of the study is to achieve superiority of transvaginal repair with mesh (Uphold LITE) over native tissue repair at 36 months as compared to baseline. Success will be based on a composite of objective and subjective measures.

Additionally, a co-primary endpoint of the study is to achieve non-inferiority of transvaginal repair with mesh (Uphold LITE) to native tissue repair for safety by comparing rates of serious device or serious procedure related complications between baseline and the 36 month time point.

The secondary endpoints of the study include assessments of complications and subject reported outcomes.


Pelvic Organ Prolapse POP Transvaginal Native Tissue Repair Repair Augmented with Mesh Prolapse Uphold Lightweight Vaginal Support System Traditional native tissue repair


You can join if…

Open to females ages 18-100

  1. Subject is female
  2. Subject is ≥18 years of age
  3. Subject has pelvic organ prolapse with the leading edge at or beyond the hymen. At or beyond the hymen is defined as POP-Q scores of Ba≥0 or (for prolapse of the anterior compartment alone) C≥0 (for prolapse of the apical compartment alone) or C≥-1/2 TVL and Ba≥0 (for a multi-compartment prolapse that includes the anterior and apical compartments).
  4. Subject reports of a bothersome bulge they can see or feel per PFDI-20, question 3 response of 2 or higher (i.e. responses of "somewhat", "moderately" or "quite a bit")
  5. Subject or subject's legally authorized representative must be willing to provide written informed consent
  6. Subject is willing and able to comply with the follow-up regimen

You CAN'T join if...

  1. Subject has an active or chronic systemic infection including any gynecologic infection, untreated urinary tract infection (UTI) or tissue necrosis
  2. Subject has history of pelvic organ cancer (e.g. uterine, ovarian, bladder, colo-rectal or cervical)
  3. Subject has had prior or is currently undergoing radiation, laser therapy, or chemotherapy in the pelvic area
  4. Subject has taken systemic steroids (within the last month) or immunosuppressive or immunomodulatory treatment (within the last 3 months)
  5. Subject has systemic connective tissue disease (e.g. scleroderma, systemic lupus erythematosus (SLE), Marfans syndrome, Ehlers Danlos collagenosis, polymyositis polymyalgia rheumatica)
  6. Subject has a known neurologic or medical condition affecting bladder function (e.g. multiple sclerosis, spinal cord injury, or stroke with residual neurologic deficit)
  7. Subject is seeking obliterative vaginal surgery as treatment for pelvic organ prolapse (colpocleisis)
  8. Subject has a previous prolapse repair with mesh in the target compartment
  9. Subject is planning to undergo a concomitant repair with use of mesh in the non-target compartment
  10. . Subject is not able to conform to the modified dorsal lithotomy position
  11. . Subject has chronic systemic pain that includes the pelvic area or chronic focal pain that includes the pelvis
  12. . Subject has uncontrolled diabetes mellitus (DM)
  13. . Subject is currently participating in or plans to participate in another device or drug study during this study
  14. . Subject has a known hypersensitivity to polypropylene mesh
  15. . Subject is pregnant or intends to become pregnant during the study


  • University of CA Irvine Medical Center
    Orange California 92868 United States
  • Scripps Clinic Carmel Valley
    San Diego California 92130 United States

Lead Scientist


in progress, not accepting new patients
Start Date
Completion Date
Boston Scientific Corporation
Study Type
Last Updated